Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Phase 4 Completed 284 enrolled Biogen

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was to find out if patients with Relapsing Remitting Multiple Sclerosis treated with Interferon beta-1a had an improved quality of life after treatment with Interferon beta-1a

Timeline

Start: 1999-11
Primary completion: —
Completion: 2004-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Interferon beta-1a	Protein / enzyme biologic	—	Intramuscular

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Summary

Timeline

Drugs

Indications